Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


17.09.2018

1 Am J Gastroenterol
1 Dig Dis
2 Eur J Gastroenterol Hepatol
1 Gastroenterol Hepatol
7 Gastroenterology
1 Gut
4 Inflamm Bowel Dis
12 J Crohns Colitis
1 PLoS Genet
2 Scand J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. ALMARIO CV, Chen MS, Spiegel BMR
    Reply to Johnson et al. Regarding Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
    Am J Gastroenterol. 2018 Sep 13. pii: 10.1038/s41395-018-0279.
    PubMed     Text format    


    Dig Dis

  2. SUGIMOTO K, Ikeya K, Kato M, Matsuura A, et al
    Assessment of Long-Term Efficacy and Safety of Adalimumab in Patients with Ulcerative Colitis: Results from a 6-Year Real-World Clinical Practice.
    Dig Dis. 2018 Sep 11:1-10. doi: 10.1159/000493121.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  3. JUNG ES, Petersen BS, Mayr G, Cheon JH, et al
    Compound heterozygous mutations in IL10RA combined with a complement factor properdin mutation in infantile-onset inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2018 Sep 7. doi: 10.1097/MEG.0000000000001247.
    PubMed     Text format     Abstract available

  4. MOSLI M, Alfaer S, Almalaki T, Albeshry A, et al
    Baseline risk assessment of patients with ulcerative colitis: does initial treatment selection influence outcomes?
    Eur J Gastroenterol Hepatol. 2018 Sep 7. doi: 10.1097/MEG.0000000000001249.
    PubMed     Text format     Abstract available


    Gastroenterol Hepatol

  5. MERINO RODRIGUEZ E, Carrera Alonso E, Torralba Gonzalez de Suso M, Sanchez da Silva M, et al
    Ionizing diagnostic radiation exposure in patients with Crohn's disease: A retrospective study in a medium hospital and its predictive factors.
    Gastroenterol Hepatol. 2018;41:97-102.
    PubMed     Text format     Abstract available


    Gastroenterology

  6. CHEBLI JMF, de Oliveira Moreira B, da Rocha Ribeiro TC
    An Unusual Cause of Skin Rash in Crohn's Disease.
    Gastroenterology. 2018;155:618-620.
    PubMed     Text format    

  7. VANDUSSEN KL, Stojmirovic A, Li K, Liu TC, et al
    Abnormal Small Intestinal Epithelial Microvilli in Patients With Crohn's Disease.
    Gastroenterology. 2018;155:815-828.
    PubMed     Text format     Abstract available

  8. CLERC F, Novokmet M, Dotz V, Reiding KR, et al
    Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases.
    Gastroenterology. 2018;155:829-843.
    PubMed     Text format     Abstract available

  9. MATRO R, Martin CF, Wolf D, Shah SA, et al
    Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development.
    Gastroenterology. 2018;155:696-704.
    PubMed     Text format     Abstract available

  10. DULAI PS, Boland BS, Singh S, Chaudrey K, et al
    Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.
    Gastroenterology. 2018;155:687-695.
    PubMed     Text format     Abstract available

  11. KANEIDER NC, Kaser A
    Personalized Treatment in Inflammatory Bowel Disease: For Another Time.
    Gastroenterology. 2018 Sep 8. pii: S0016-5085(18)34937.
    PubMed     Text format    

  12. DULAI PS
    Methotrexate Monotherapy for Induction and Maintenance of Clinical Remission in Ulcerative Colitis: Dead on Arrival.
    Gastroenterology. 2018 Sep 8. pii: S0016-5085(18)34940.
    PubMed     Text format    


    Gut

  13. XU P, Becker H, Elizalde M, Masclee A, et al
    Intestinal organoid culture model is a valuable system to study epithelial barrier function in IBD.
    Gut. 2018;67:1905-1906.
    PubMed     Text format    


    Inflamm Bowel Dis

  14. REICH J, Guo L, Groshek J, Weinberg J, et al
    Social Media Use and Preferences in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Sep 7. pii: 5092671. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. BORREN NZ, Khalili H, Luther J, Colizzo FP, et al
    Second-Look Endoscopy in Hospitalized Severe Ulcerative Colitis: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2018 Sep 11. pii: 5094888. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. MINACAPELLI CD, Bajpai M, Geng X, Van Gurp J, et al
    miR-206 as a Biomarker for Response to Mesalamine Treatment in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Sep 11. pii: 5094859. doi: 10.1093.
    PubMed     Text format     Abstract available

  17. ZHENG C, Huang Y, Hu W, Shi J, et al
    Phenotypic Characterization of Very Early-Onset Inflammatory Bowel Disease with Interleukin-10 Signaling Deficiency: Based on a Large Cohort Study.
    Inflamm Bowel Dis. 2018 Sep 13. pii: 5096668. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Crohns Colitis

  18. SRINIVASAN A, Vasudevan A, McFarlane A, Sparrow MP, et al
    Anti-TNF Re-induction Is as Effective, Simpler, and Cheaper Compared With Dose Interval Shortening for Secondary Loss of Response in Crohn's Disease.
    J Crohns Colitis. 2018;12:280-288.
    PubMed     Text format     Abstract available

  19. BESWICK L, Rosella O, Rosella G, Headon B, et al
    Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot Study.
    J Crohns Colitis. 2018;12:289-297.
    PubMed     Text format     Abstract available

  20. COHEN-DOLEV N, Sladek M, Hussey S, Turner D, et al
    Differences in Outcomes Over Time With Exclusive Enteral Nutrition Compared With Steroids in Children With Mild to Moderate Crohn's Disease: Results From the GROWTH CD Study.
    J Crohns Colitis. 2018;12:306-312.
    PubMed     Text format     Abstract available

  21. KLANG E, Amitai MM, Lahat A, Yablecovitch D, et al
    Capsule Endoscopy Validation of the Magnetic Enterography Global Score in Patients with Established Crohn's Disease.
    J Crohns Colitis. 2018;12:313-320.
    PubMed     Text format     Abstract available

  22. WANG Y, Gao X, Ghozlane A, Hu H, et al
    Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.
    J Crohns Colitis. 2018;12:337-346.
    PubMed     Text format     Abstract available

  23. ROTTOLI M, Vallicelli C, Bigonzi E, Gionchetti P, et al
    Prepouch Ileitis After Ileal Pouch-anal Anastomosis: Patterns of Presentation and Risk Factors for Failure of Treatment.
    J Crohns Colitis. 2018;12:273-279.
    PubMed     Text format     Abstract available

  24. LO B, Vester-Andersen MK, Vind I, Prosberg M, et al
    Changes in Disease Behaviour and Location in Patients With Crohn's Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort.
    J Crohns Colitis. 2018;12:265-272.
    PubMed     Text format     Abstract available

  25. VLEUGELS JLA, Rutter MD, Ragunath K, Rees CJ, et al
    Diagnostic accuracy of Endoscopic Trimodal Imaging and Chromoendoscopy for lesion characterisation in ulcerative colitis surveillance: ETMI or chromoendoscopy for lesion characterisation in colitis.
    J Crohns Colitis. 2018 Sep 8. pii: 5092911. doi: 10.1093.
    PubMed     Text format     Abstract available

  26. SVRCEK M, Borralho Nunes PM, Villanacci V, Beaugerie L, et al
    Clinicopathological and molecular specificities of inflammatory bowel disease-related colorectal neoplastic lesions: the role of inflammation.
    J Crohns Colitis. 2018 Sep 10. pii: 5094505. doi: 10.1093.
    PubMed     Text format     Abstract available

  27. FEAGAN BG, Sandborn WJ, Colombel JF, O'Byrne S, et al
    Incidence of Arthritis/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials.
    J Crohns Colitis. 2018 Sep 3. pii: 5089953. doi: 10.1093.
    PubMed     Text format     Abstract available

  28. CHAN W, Shim HH, Ng SC, Liu J, et al
    A Global Survey of Gastroenterologists' Travel Advice to Patients with Inflammatory Bowel Disease on Immunosuppressive Agents and Management of Those Visiting Tuberculosis-Endemic Areas.
    J Crohns Colitis. 2018 Sep 11. pii: 5095284. doi: 10.1093.
    PubMed     Text format     Abstract available

  29. ROWAN CR, Cullen G, Mulcahy HE, Keegan D, et al
    Ustekinumab Drug Levels in Maternal and Cord Blood in a Woman With Crohn's Disease Treated Until 33 Weeks of Gestation.
    J Crohns Colitis. 2018;12:376-378.
    PubMed     Text format     Abstract available


    PLoS Genet

  30. RICHARD AC, Peters JE, Savinykh N, Lee JC, et al
    Reduced monocyte and macrophage TNFSF15/TL1A expression is associated with susceptibility to inflammatory bowel disease.
    PLoS Genet. 2018;14:e1007458.
    PubMed     Text format     Abstract available


    Scand J Gastroenterol

  31. HAKIMIAN S, Kheder J, Arum S, Cave DR, et al
    Re-evaluating osteoporosis and fracture risk in Crohn's disease patients in the era of TNF-alpha inhibitors.
    Scand J Gastroenterol. 2018;53:168-172.
    PubMed     Text format     Abstract available

  32. LIRHUS SS, Hoivik ML, Moum B, Melberg HO, et al
    Regional differences in anti-TNF-alpha therapy and surgery in the treatment of inflammatory bowel disease patients: a Norwegian nationwide cohort study.
    Scand J Gastroenterol. 2018 Sep 12:1-6. doi: 10.1080/00365521.2018.1495258.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: